US advances first government-funded trials of psychedelic drug ibogaine
TimesLive | 06.10.2026 01:55
US health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder, the FDA said on Monday, as it sought public feedback on safety rules for the studies.
